Palliative reirradiation for progressive diffuse intrinsic pontine glioma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 1, 2012, Pages 51-57

  Fontanilla, Hiral P ^a   Pinnix, Chelsea C ^a   Ketonen, Leena M ^a   Woo, Shiao Y ^a   Vats, Tribhawan S ^a   Rytting, Michael E ^a   Wolff, Johannes E ^a   Mahajan, Anita ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

brainstem glioma; palliative radiation; pediatric brain tumors

Indexed keywords

ALEMTUZUMAB; BEVACIZUMAB; CISPLATIN; ETOPOSIDE; IRINOTECAN; LOMUSTINE; NIMOTUZUMAB; TEMOZOLOMIDE; VALPROIC ACID; VANDETANIB; VINCRISTINE;

ALOPECIA; ANOREXIA; ARTICLE; ATAXIA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CHILD; CLINICAL ARTICLE; DIFFUSE INTRINSIC PONTINE GLIOMA; FATIGUE; FEMALE; HEADACHE; HUMAN; MALE; MOBILIZATION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL (TOPIC); PONTINE GLIOMA; PRESCHOOL CHILD; RADIATION DOSE; RETREATMENT; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCHOOL CHILD; SPEECH; SURVIVAL TIME; SWALLOWING; TOXICITY; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN STEM NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MEDICAL RECORDS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PONS; PONTINE GLIOMA; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RETREATMENT; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; WALKING;

EID: 84856277709     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318201a2b7     Document Type: Article

References (31)

1. Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys. 1998;40:265-271. (Pubitemid 28114367)
2. Fangusaro J. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas. J Child Neurol. 2009;24:1409-1417.
3. Freeman CR, Krischer JP, Sanford RA, et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys. 1993;27:197-206. (Pubitemid 23304443)
4. Packer RJ, Boyett JM, Zimmerman RA, et al. Hyperfractionated radiation therapy (72Gy) for children with brain stem gliomas. A Children's Cancer Group phase I/II trial. Cancer. 1993;72:1414-1421.
5. Farmer JP, Montes JL, Freeman CR, et al. Brainstem gliomas. A 10-year institutional review. Pediatr Neurosurg. 2001;34:206-214. (Pubitemid 32453752)
6. Allen JC, Siffert J. Contemporary chemotherapy issues for children with brainstem gliomas. Pediatr Neurosurg. 1996;24: 98-102. (Pubitemid 26226239)
7. Bauman GS, Sneed PK, Wara WM, et al. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys. 1996;36: 433-441. (Pubitemid 26359470)
8. Arcicasa M, Roncadin M, Bidoli E, et al. Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys. 1999;43:789-793. (Pubitemid 29152651)
9. Kim HK, Thornton AF, Greenberg HS, et al. Results of re-irradiation of primary intracranial neoplasms with threedimensional conformal therapy. Am J Clin Oncol. 1997;20: 358-363. (Pubitemid 27329567)
10. Dritschilo A, Bruckman JE, Cassady JR, et al. Tolerance of brain to multiple courses of radiation therapy. I. Clinical experiences. Br J Radiol. 1981;54:782-786. (Pubitemid 11008336)
11. Merchant TE, Boop FA, Kun LE, et al. A retrospective study of surgery and reirradiation for recurrent ependymoma. Int J Radiat Oncol Biol Phys. 2008;71:87-97. (Pubitemid 351491399)
12. Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys. 2008;70:1350-1360. (Pubitemid 351417752)
13. Macdonald DR, Cascino TL, Schold SC Jr, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8:1277-1280. (Pubitemid 20195640)
14. Henson JW, Ulmer S, Harris GJ. Brain tumor imaging in clinical trials. AJNR Am J Neuroradiol. 2008;29:419-424. (Pubitemid 351424049)
15. Jalali R, Raut N, Arora B, et al. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys. 2010;77:113-118.
16. Greenberg ML, Fisher PG, Freeman C, et al. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatr Blood Cancer. 2005;45:644-648. (Pubitemid 41282815)
17. Korones DN, Fisher PG, Kretschmar C, et al. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study. Pediatr Blood Cancer. 2008;50:227-230.
18. Wolff JE, Driever PH, Erdlenbruch B, et al. Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer. 2010;116:705-712.
19. Nieder C, Milas L, Ang KK. Tissue tolerance to reirradiation. Semin Radiat Oncol. 2000;10:200-209. (Pubitemid 30452636)
20. Floyd NS, Woo SY, Teh BS, et al. Hypofractionated intensitymodulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2004;58:721-726. (Pubitemid 38221127)
21. Liu AK, Foreman NK, Gaspar LE, et al. Maximally safe resection followed by hypofractionated re-irradiation for locally recurrent ependymoma in children. Pediatr Blood Cancer. 2009;52: 804-807.
22. Abe M, Tokumaru S, Tabuchi K, et al. Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas. Pediatr Neurosurg. 2006;42:81-88. (Pubitemid 43213919)
23. Sharma MS, Kondziolka D, Khan A, et al. Radiation tolerance limits of the brainstem. Neurosurgery. 2008;63:728-732; discussion 732-723.
24. Nelson MD Jr, Soni D, Baram TZ. Necrosis in pontine gliomas: radiation induced or natural history? Radiology 1994;191: 279-282. (Pubitemid 24098246)
25. Schultheiss TE, Kun LE, Ang KK, et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 1995;31: 1093-1112.
26. Gonzalez J, Kumar AJ, Conrad CA, et al. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys. 2007;67:323-326. (Pubitemid 46108339)
27. Liu AK, Macy ME, Foreman NK. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys. 2009;75:1148-1154.
28. Wong ET, Huberman M, Lu XQ, et al. Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol. 2008;26:5649-5650.
29. Torcuator R, Zuniga R, Mohan YS, et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol. 2009;94:63-68.
30. Narayana A, Golfinos JG, Fischer I, et al. Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma. Int J Radiat Oncol Biol Phys 2008;72:383-389.
31. Gururangan S, Chi SN, Young Poussaint T, et al. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. J Clin Oncol. 2010;28:3069-3075.